Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Biden to push U.S. Congress for money to fight pandemic globally

Published 01/21/2021, 05:51 PM
Updated 01/21/2021, 05:55 PM
© Reuters

By Michelle Nichols

NEW YORK (Reuters) - The United States will back a global plan to combat COVID-19 and get vaccines to poorer countries as part of a national strategy unveiled by President Joe Biden on Thursday, which includes pushing Congress for more funding for international efforts.

Global re-engagement has been among Biden's priorities since taking office on Wednesday and one his first actions was to rescind former President Donald Trump's planned withdrawal from the Geneva-based World Health Organization (WHO).

Under the U.S. COVID-19 strategy, Biden will direct his secretary of state and secretary of health and human services to notify the WHO and the GAVI vaccine alliance of Washington's intent to support the Access to COVID-19 Tools (ACT) Accelerator and join its COVAX facility.

Vice President Kamala Harris spoke with WHO Director-General Tedros Adhanom Ghebreyesus on Thursday about Washington's plans, the White House said.

The ACT-Accelerator programme and its COVAX facility are the global plan to tackle the pandemic, aiming to deliver 2 billion doses of coronavirus vaccines by the end of 2021, 245 million treatments and 500 million tests. The first vaccine batches are expected to go to poorer countries in February.

"The Biden-Harris Administration will seek funding from Congress to strengthen and sustain these efforts, as well as other existing multilateral initiatives involved in fighting COVID-19," according to the strategy, which also calls for Washington to work on a way to donate any future U.S. vaccine surplus.

In December the U.S. Congress allocated $4 billion for the global response to the pandemic, including vaccine procurement and delivery. But Biden's nominee for secretary of state, Antony Blinken, warned that "additional resources are likely to be to be needed."

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

So far the ACT-Accelerator has received $6 billion and the U.S. pledge of $4 billion, but still needs another $23 billion.

Blinken said it was in the U.S. national interest to make sure vaccines are effectively and quickly distributed globally.

"We're seeing the potential for a debt crisis among emerging economies and developing economies. We're seeing public health crises in country after country because COVID has made it more difficult to provide other health services," Blinken said.

"We're seeing state fragility increase, not decrease ... so we have actual interest in helping," he said on Tuesday.

Blinken also described WHO as an "imperfect organization in need of reform," but said it was better to tackle it as a member. Trump had cut funding to the WHO last year and announced plans to quit the body over accusations it was a puppet of China, which WHO denied.

 

Latest comments

Swamp gonna swamp
Biden = America last
how about fight rioting in Portland
Biden said well vaccinate 100mil ppl in 100 days. We’re doing 1mil/day now haha. Get used to a whole lotta nothing😆😆😅
The powers that be think the market is bubbled. Good luck pushing them for anything more money
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.